Compare ARMP & TAYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARMP | TAYD |
|---|---|---|
| Founded | N/A | 1955 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 156.4M | 170.7M |
| IPO Year | 1996 | 1995 |
| Metric | ARMP | TAYD |
|---|---|---|
| Price | $4.75 | $54.86 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | $15.00 | ★ $70.00 |
| AVG Volume (30 Days) | ★ 166.3K | 30.2K |
| Earning Date | 05-07-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.24 |
| EPS | N/A | ★ 2.87 |
| Revenue | N/A | ★ $46,292,725.00 |
| Revenue This Year | N/A | $0.25 |
| Revenue Next Year | N/A | $19.78 |
| P/E Ratio | ★ N/A | $18.15 |
| Revenue Growth | N/A | ★ 3.84 |
| 52 Week Low | $2.36 | $40.50 |
| 52 Week High | $14.98 | $90.37 |
| Indicator | ARMP | TAYD |
|---|---|---|
| Relative Strength Index (RSI) | 39.95 | 47.43 |
| Support Level | $3.48 | $53.46 |
| Resistance Level | $7.67 | $59.13 |
| Average True Range (ATR) | 0.56 | 2.26 |
| MACD | 0.13 | -0.15 |
| Stochastic Oscillator | 53.96 | 35.86 |
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.